Titan Biotech Ltd

NSE: TITANBIO · BSE: 524717 · Chemicals & Petrochemicals · 16 announcements

Share price: ₹401.00
Market cap: ₹1,657 Cr
Revenue (annual): ₹206.2 Cr
Net profit (annual): ₹29.89 Cr
P/E (TTM): 48.9×Sector 37.2×
Promoter holding: 55.78%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 3 Other Announcement 2 Legal & Regulatory 1 Dividend 1 Debt & Borrowing 1 Bonus Issue 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 May 2026 16:04 IST BSE

Board Meeting Outcome

Titan Biotech Board Meeting Outcome

Titan Biotech Ltd board approved re-appointing M/s Sanjay Kumar Garg & Associates as Cost Auditors for FY 2026-27. The appointment remains subject to shareholder ratification.

Execution: FY 2026-2027

Read the filing ↗